698 related articles for article (PubMed ID: 31624894)
41. A Cautionary Tale and Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
Ghosh T; Duncavage E; Mehta-Shah N; McGuire PA; Tenenbaum M; Myckatyn TM
Aesthet Surg J; 2020 Nov; 40(12):1288-1300. PubMed ID: 31894234
[TBL] [Abstract][Full Text] [Related]
42. [Thirty-six (36) French cases of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): What do we know about their prosthetic histories, and what conclusions may be drawn?].
Ruffenach L; Bruant-Rodier C; Goldammer F; Ramelli E; Bodin F; Dissaux C
Ann Chir Plast Esthet; 2019 Aug; 64(4):285-292. PubMed ID: 31331683
[TBL] [Abstract][Full Text] [Related]
43. Breast Implant-Associated Anaplastic Large Cell Lymphoma: Proposal for a Monitoring Protocol.
Santanelli di Pompeo F; Laporta R; Sorotos M; Di Napoli A; Giovagnoli MR; Cox MC; Campanale A; Longo B
Plast Reconstr Surg; 2015 Aug; 136(2):144e-151e. PubMed ID: 26218387
[TBL] [Abstract][Full Text] [Related]
44. Breast Implant-Associated Lymphoma.
Kricheldorff J; Fallenberg EM; Solbach C; Gerber-Schäfer C; Rancsó C; Fritschen UV
Dtsch Arztebl Int; 2018 Sep; 115(38):628-635. PubMed ID: 30373708
[TBL] [Abstract][Full Text] [Related]
45. [Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL)].
Hedén P; Stark B
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29917175
[TBL] [Abstract][Full Text] [Related]
46. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
[TBL] [Abstract][Full Text] [Related]
47. Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Updated Systematic Review and Analysis of Treatment Strategies.
Naga HI; Mellia JA; Basta MN; Morris MP; Christopher AN; Campbell FM; Sommers K; Levinson H; Nelson JA; Fischer JP
Plast Reconstr Surg; 2022 Oct; 150(4):762-769. PubMed ID: 35862104
[TBL] [Abstract][Full Text] [Related]
48. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
[TBL] [Abstract][Full Text] [Related]
49. Zwitterionic polymer on silicone implants inhibits the bacteria-driven pathogenic mechanism and progress of breast implant-associated anaplastic large cell lymphoma.
Kim J; Kang S; Choi MH; Park S; Nam SH; Park JU; Lee Y
Acta Biomater; 2023 Nov; 171():378-391. PubMed ID: 37683967
[TBL] [Abstract][Full Text] [Related]
50. The Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma; A Systematic Review and Meta-Analysis.
Elameen AM; AlMarakby MA; Atta TI; Dahy AA
Aesthetic Plast Surg; 2024 May; ():. PubMed ID: 38724638
[TBL] [Abstract][Full Text] [Related]
51. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Updated Report 2012-2020.
McCarthy CM; Roberts J; Mullen E; Loyo-Berrios N; Clemens MW; Yoon SW; Levinson H; Sommers K; Hume K; Carr L
Plast Reconstr Surg; 2023 Oct; 152(4S):16S-24S. PubMed ID: 36995215
[TBL] [Abstract][Full Text] [Related]
52. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants.
Locke MB; Lofts J
ANZ J Surg; 2017 Oct; 87(10):789-794. PubMed ID: 25827224
[TBL] [Abstract][Full Text] [Related]
53. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
[TBL] [Abstract][Full Text] [Related]
54. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
[TBL] [Abstract][Full Text] [Related]
55. Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Systematic Review.
Leberfinger AN; Behar BJ; Williams NC; Rakszawski KL; Potochny JD; Mackay DR; Ravnic DJ
JAMA Surg; 2017 Dec; 152(12):1161-1168. PubMed ID: 29049466
[TBL] [Abstract][Full Text] [Related]
56. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
Kadin ME; Adams WP; Inghirami G; Di Napoli A
Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
[TBL] [Abstract][Full Text] [Related]
57. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review.
Santanelli di Pompeo F; Clemens MW; Paolini G; Firmani G; Panagiotakos D; Sorotos M
Aesthet Surg J; 2023 Dec; 44(1):NP32-NP40. PubMed ID: 37616552
[TBL] [Abstract][Full Text] [Related]
58. Implications of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) for Breast Cancer Reconstruction: An Update for Surgical Oncologists.
O'Neill AC; Zhong T; Hofer SOP
Ann Surg Oncol; 2017 Oct; 24(11):3174-3179. PubMed ID: 28762113
[TBL] [Abstract][Full Text] [Related]
59. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
[TBL] [Abstract][Full Text] [Related]
60. Breast Implant-Associated Anaplastic Large Cell Lymphoma Awareness: An Analysis of the Responses to an Institutional Campaign and Global Recall.
Mason MM; Kuruoglu D; Zheng EE; Kerivan LT; Nguyen MT
Ann Plast Surg; 2023 Nov; 91(5):529-533. PubMed ID: 37823619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
